Guardian Pharmacy Services (NYSE:GRDN) Sets New 12-Month High After Better-Than-Expected Earnings
by Danessa Lincoln · The Markets DailyGuardian Pharmacy Services, Inc. (NYSE:GRDN – Get Free Report) shares reached a new 52-week high during mid-day trading on Friday following a better than expected earnings announcement. The company traded as high as $45.80 and last traded at $45.7110, with a volume of 43324 shares changing hands. The stock had previously closed at $39.47.
The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 3.64% and a return on equity of 30.72%. The company had revenue of $351.77 million during the quarter, compared to analysts’ expectations of $340.45 million.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on GRDN. Wall Street Zen cut Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Zacks Research cut Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Truist Financial boosted their price objective on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Oppenheimer reissued an “outperform” rating and issued a $49.00 price objective (up from $43.00) on shares of Guardian Pharmacy Services in a research note on Friday. Finally, Weiss Ratings cut shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 11th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $43.83.
Check Out Our Latest Stock Analysis on Guardian Pharmacy Services
Hedge Funds Weigh In On Guardian Pharmacy Services
A number of institutional investors have recently made changes to their positions in the stock. Ameritas Investment Partners Inc. grew its stake in Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after acquiring an additional 345 shares during the period. California State Teachers Retirement System lifted its stake in shares of Guardian Pharmacy Services by 3.4% during the 4th quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock worth $541,000 after purchasing an additional 593 shares during the period. Police & Firemen s Retirement System of New Jersey lifted its stake in shares of Guardian Pharmacy Services by 20.4% during the 4th quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock worth $183,000 after purchasing an additional 1,028 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of Guardian Pharmacy Services by 13.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 11,885 shares of the company’s stock worth $358,000 after purchasing an additional 1,409 shares during the last quarter. Finally, Clearstead Advisors LLC grew its position in shares of Guardian Pharmacy Services by 196.3% in the fourth quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock valued at $79,000 after purchasing an additional 1,741 shares during the period.
Guardian Pharmacy Services Price Performance
The firm has a market cap of $2.21 billion, a PE ratio of 53.78, a P/E/G ratio of 2.73 and a beta of 0.10. The stock has a 50-day moving average price of $40.84 and a 200 day moving average price of $37.05.
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.